Emesis and Nasal therapy in chronic plaque psoriasis

A Randomized Comparative Controlled Clinical Study On Efficacy of Vaman And Nasya Karma In The Management Of Mandal Kushtha With Special Reference To Chronic Plaque Psoriasis. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083338

Enrollment

Registered

2025-03-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: (a) Patient with the classical feature of Mandal kustha (plaque psoriasis) (b) Patient not taking any other medication for Mandal kustha (plaque psoriasis) (c) Patient fit for Vaman and Nasya Karma (d) Patient willing to sign consent form for trial (e) The participant with combined PASI score more than 5 to less than 72 will be included (moderate to severe form)

Exclusion criteria

Exclusion criteria: (a) Age below the age 18 years & above the age 60 years (b) Patients suffering from systemic disorders as cardiac problem, uncontrolled Diabetes mellitus, uncontrolled Hypertension, paralysis, malignancy, HIV, HBsAg, Leprosy (c) Patient suffering from Psoriatic Arthritis (d) pregnant and lactating mothers. (e) patient unfit for Vamana and Nasya Karma

Design outcomes

Primary

Measure	Time frame
changes in PASI Score (psoriasis area and severity index)Timepoint: Baseline, 14th day, and 28th day	—

Secondary

Measure	Time frame
(a) changes in DLOI (The Dermatology Life Quality Index) (b) compliance of both the procedure Vamana & Nasya Timepoint: Baseline, 14th day, & 28th day	—

Countries

India

Contacts

Public ContactDr Sarvesh Kumar Singh

National institute of Ayurveda

sarveshksingh21@gmail.com8739860237

Outcome results